Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 8, 2006, Pages 617-623

  Kim, Dong Hyun ^a   Park, Yong Soo ^a,c   Jeon, Eun Ju ^b   Yeo, Sang Won ^b   Chang, Ki Hong ^b   Lee, Seung Kyun ^b  

^a Ajou University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Our Lady Mercy Hospital   (South Korea)

Author keywords

Nitric oxide synthase inhibitor; Otitis media with effusion; Platelet activating factor antagonist; Tumor necrosis factor alpha antagonist

Indexed keywords

6 (4 FLUOROPHENYL) 3 [[3 (3 PYRIDYL) 1H,3H PYRROLO[1,2 C]THIAZOL 7 YL]CARBONYL] 1 INDOLECARBOXYLIC ACID DIMETHYLAMIDE; EVANS BLUE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; EDEMA; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; MIDDLE EAR MUCOSA; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SECRETORY OTITIS MEDIA; TEMPORAL BONE;

EID: 33747437643     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500808     Document Type: Article

References (18)

1. Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991;101:165-9.
2. Yellon RF, Doyle WJ, Whiteside TL, Diven WF, March AR, Fireman P. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg 1995;121:865-9.
3. [Erratum in Arch Otolaryngol Head Neck Surg 1995;121:1402.]
4. Himi T, Suzuki T, Kodama H, Takezawa H, Kataura A. Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 1992;101(suppl 157): 21-5.
5. Rhee CK, Jung TT, Miller S, Weeks D. Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 1993;102:600-5.
6. Rose AS, Prazma J, Randell SH, Baggett HC, Lane AP, Pillsbury HC. Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion. Otolaryngol Head Neck Surg 1997;116:308-16.
7. Rhee CK. Platelet-activating factor-induced hearing loss: mediated by nitric oxide? Laryngoscope 2003;113:2059-66.
8. Jeon EJ, Park YS, Choi YC, Yeo SW, Jung TTK. Effect of inhibitor of tumor necrosis factor-alpha on experimental otitis media with effusion. Ann Otol Rhinol Laryngol 2001;110:917-21.
9. Lee DH, Park YS, Jung TTK, Yeo SW, Choi YH, Jeon E. Effect of tumor necrosis factor-α on experimental otitis media with effusion. Larygoscope 2001;111:728-33.
10. Karasen RM, Sutbeyaz Y, Aktan B, Ozdemir H, Gundogdu C. Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the guinea pig model of middle ear inflammation. Ann Otol Rhinol Laryngol 2000;109:549-53.
11. Ball SS, Prazma J, Dais D, Rosbe KW, Pillsbury HC. Nitric oxide: a mediator of endotoxin-induced middle ear effusions. Laryngoscope 1996;106:1021-7.
12. Ryan AF, Bennett T. Nitric oxide contributes to control of effusion in experimental otitis media. Laryngoscope 2001; 111:301-5.
13. Catanzaro A, Ryan A, Batcher S, Wasserman SI. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs. Laryngoscope 1991;101:271-5.
14. Ball SS, Prazma J, Dais CG, Triana RJ, Pillsbury HC. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions. Ann Otol Rhinol Laryngol 1997; 106:633-9.
15. Maxwell K, Leonard G, Kreutzer DL. Cytokine expression on otitis media with effusion. Tumor necrosis factor soluble receptor. Arch Otolaryngol Head Neck Surg 1997;123:984-8.
16. Juhn SK, Garvis WJ, Lees CJ, Le CT, Kim CS. Determining otitis media severity from middle ear fluid analysis. Ann Otol Rhinol Laryngol Suppl 1994;103(suppl 163):43-5.
17. Hebda PA, Burckart GJ, Alper CM, et al. Effect of 10 pharmacologic probes on mRNA levels of inducible nitric oxide synthase and selected inflammatory cytokines in a rat model of acute otitis media. Acta Otolaryngol (Stockh) 2002;122:255-61.
18. DeMaria TF, Prior RB, Briggs BR, Lim DJ, Birck HG. Endotoxin in middle-ear effusions from patient with chronic otitis media with effusion. J Clin Microbiol 1984;20:15-7.